JP2023510223A5 - - Google Patents

Info

Publication number
JP2023510223A5
JP2023510223A5 JP2022540995A JP2022540995A JP2023510223A5 JP 2023510223 A5 JP2023510223 A5 JP 2023510223A5 JP 2022540995 A JP2022540995 A JP 2022540995A JP 2022540995 A JP2022540995 A JP 2022540995A JP 2023510223 A5 JP2023510223 A5 JP 2023510223A5
Authority
JP
Japan
Prior art keywords
melatonin
carrier material
aqueous carrier
coating
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022540995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023510223A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/050770 external-priority patent/WO2021144403A1/en
Publication of JP2023510223A publication Critical patent/JP2023510223A/ja
Publication of JP2023510223A5 publication Critical patent/JP2023510223A5/ja
Priority to JP2025134129A priority Critical patent/JP2025169319A/ja
Pending legal-status Critical Current

Links

JP2022540995A 2020-01-17 2021-01-15 徐放性メラトニンペレットを含む剤形 Pending JP2023510223A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025134129A JP2025169319A (ja) 2020-01-17 2025-08-12 徐放性メラトニンペレットを含む剤形

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062962574P 2020-01-17 2020-01-17
US62/962,574 2020-01-17
PCT/EP2021/050770 WO2021144403A1 (en) 2020-01-17 2021-01-15 Dosage form with sustained release melatonin pellets

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025134129A Division JP2025169319A (ja) 2020-01-17 2025-08-12 徐放性メラトニンペレットを含む剤形

Publications (2)

Publication Number Publication Date
JP2023510223A JP2023510223A (ja) 2023-03-13
JP2023510223A5 true JP2023510223A5 (https=) 2024-01-15

Family

ID=74285447

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022540995A Pending JP2023510223A (ja) 2020-01-17 2021-01-15 徐放性メラトニンペレットを含む剤形
JP2025134129A Pending JP2025169319A (ja) 2020-01-17 2025-08-12 徐放性メラトニンペレットを含む剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025134129A Pending JP2025169319A (ja) 2020-01-17 2025-08-12 徐放性メラトニンペレットを含む剤形

Country Status (8)

Country Link
US (2) US11723862B2 (https=)
EP (1) EP4090315A1 (https=)
JP (2) JP2023510223A (https=)
CN (1) CN114901256A (https=)
AU (1) AU2021207284B2 (https=)
BR (1) BR112022012199A2 (https=)
CA (1) CA3163378A1 (https=)
WO (1) WO2021144403A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024079125A1 (en) 2022-10-14 2024-04-18 Société des Produits Nestlé S.A. Sustained release melatonin compositions
CN116172979B (zh) * 2023-02-15 2024-10-15 浙江贝灵生物医药有限公司 一种褪黑素缓释小丸及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003043A1 (en) * 1993-07-26 1995-02-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Sustained release oral compositions containing melatonin
JP4641696B2 (ja) * 1999-09-30 2011-03-02 大塚製薬株式会社 消化管下部溶解性コーティング製剤
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
KR100501827B1 (ko) 2002-09-24 2005-07-20 한국화학연구원 다층 코팅법을 이용한 멜라토닌 함유 타게팅 약물 전달 기구
US20070298117A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and a chondroprotective component
US20070299127A1 (en) * 2006-06-23 2007-12-27 The Procter & Gamble Company Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
US20080171085A1 (en) * 2007-01-11 2008-07-17 Natrol, Inc. Novel biphasic delivery system for a pharmaceutical or nutraceutical composition and method of administration
WO2011160003A1 (en) * 2010-06-17 2011-12-22 Antioxidant Superfoods, Inc. Improved health characteristic chewy or gummy candy confection
WO2012103411A2 (en) * 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US20120315337A1 (en) 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
ITMI20112042A1 (it) * 2011-11-10 2013-05-11 Eratech S R L Polvere da ricostituire prima dell'uso comprendente melatonina e preparazione iniettabile ottenibile da tale polvere.
CA3013472A1 (en) * 2016-02-11 2017-08-17 Biogen Ma Inc. Pharmaceutical bead formulations comprising dimethyl fumarate
WO2017192843A1 (en) * 2016-05-06 2017-11-09 Physician's Seal, LLC Valerian composition and related methods
GR1009541B (el) 2018-02-26 2019-06-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα φαρμακευτικα διαλυματα που περιλαμβανουν μελατονινη
CN113490491A (zh) * 2019-01-18 2021-10-08 雀巢产品有限公司 固体微粉化褪黑激素组合物

Similar Documents

Publication Publication Date Title
ES2336913T3 (es) Comprimido de liberacion modificada de hidrocloruro de bupropion.
CA1148084A (en) Dipyridamol sustained release forms and processes for the preparation thereof
JP5607670B2 (ja) 時限拍動性薬物送達システム
US9078830B2 (en) Multi-layered, multiple unit pharmaceutical compositions
JP2020059755A (ja) 時限パルス放出システム
HU186538B (en) Process for producing retarde pharmaceutical compositions containing bromohexine
CZ296067B6 (cs) Potazená jádra s opozdeným uvolnováním úcinné látky a farmaceutické dávkovací formy je obsahující
CN1335768A (zh) 多颗粒改进释放组合物
JP2017128614A5 (https=)
JP2023510223A5 (https=)
JPH06509809A (ja) 短時間で医薬を放出する投与形態
CN116546978A (zh) Janus激酶(jak)抑制剂的延迟缓释口服药物剂型及其使用方法
EP2361616A1 (en) Extended release compositions for high solubility, high permeability active pharmaceutical ingredients
WO2013183497A1 (ja) 有核錠
CN1305371A (zh) 程序化和随时间释放的多颗粒药物剂型及其制备方法
CN103751137B (zh) 雷诺嗪多单元缓释微丸片
Patel et al. Multiparticulate approach: an emerging trend in colon specific drug delivery for chronotherapy
JPH0635383B2 (ja) ケトプロフエンの経口投与のための放出が制御された錠剤及びその製造方法
CN1681493A (zh) 掩味舒马曲坦片剂及其制备方法
CN102764243B (zh) 一种阿司匹林脉冲释放微丸和其制剂及其制备方法
CN101411702B (zh) 盐酸奈福泮萘普生钠复方缓释制剂及其制备方法
CN109966269A (zh) 一种盐酸美金刚缓释微丸制剂及其制备方法
CN100345541C (zh) 可控缓释培哚普利微囊
JP2008542394A (ja) 少なくとも1つの形態のベンラファキシンの調節放出性組成物
US20240342104A1 (en) Dosage form for improving palatability of drug substance